{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:12:50Z","timestamp":1761718370638},"reference-count":77,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2015,1,27]],"date-time":"2015-01-27T00:00:00Z","timestamp":1422316800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0114050","type":"journal-article","created":{"date-parts":[[2015,1,27]],"date-time":"2015-01-27T18:46:27Z","timestamp":1422384387000},"page":"e0114050","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["The Effects of Two Polymorphisms on p21cip1 Function and Their Association with Alzheimer\u2019s Disease in a Population of European Descent"],"prefix":"10.1371","volume":"10","author":[{"given":"Sharon C.","family":"Yates","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amen","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erzsebet M.","family":"Rabai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James B.","family":"Foxall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen E.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret M.","family":"Esiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Christie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. David","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsuzsanna","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,1,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","article-title":"Alzheimer\u2019s disease","volume":"377","author":"C Ballard","year":"2011","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","article-title":"Role of genes and environments for explaining Alzheimer disease","volume":"63","author":"M Gatz","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1755-8794-1-44","article-title":"A genome-wide association study for late-onset Alzheimer\u2019s disease using DNA pooling","volume":"1","author":"R Abraham","year":"2008","journal-title":"BMC Med Genomics"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ajhg.2008.12.008","article-title":"Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease","volume":"84","author":"GW Beecham","year":"2009","journal-title":"Am J Hum Genet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ajhg.2008.10.008","article-title":"Genome-wide association analysis reveals putative Alzheimer\u2019s disease susceptibility loci in addition to APOE","volume":"83","author":"L Bertram","year":"2008","journal-title":"Am J Hum Genet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/hmg\/ddg007","article-title":"Results of a high-resolution genome screen of 437 Alzheimer\u2019s disease families","volume":"12","author":"D Blacker","year":"2003","journal-title":"Hum Mol Genet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/ng.305","article-title":"Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer\u2019s disease","volume":"41","author":"MM Carrasquillo","year":"2009","journal-title":"Nat Genet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/hmg\/ddm031","article-title":"Evidence for novel susceptibility genes for late-onset Alzheimer\u2019s disease from a genome-wide association study of putative functional variants","volume":"16","author":"A Grupe","year":"2007","journal-title":"Hum Mol Genet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease","volume":"41","author":"D Harold","year":"2009","journal-title":"Nat Genet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng.803","article-title":"Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer\u2019s disease","volume":"43","author":"P Hollingworth","year":"2011","journal-title":"Nat Genet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease","volume":"41","author":"JC Lambert","year":"2009","journal-title":"Nat Genet"},{"key":"ref12","first-page":"45","article-title":"Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease","volume":"65","author":"H Li","year":"2008","journal-title":"Arch Neurol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.801","article-title":"Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer\u2019s disease","volume":"43","author":"AC Naj","year":"2011","journal-title":"Nat Genet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.neuron.2007.05.022","article-title":"GAB2 alleles modify Alzheimer\u2019s risk in APOE epsilon4 carriers","volume":"54","author":"EM Reiman","year":"2007","journal-title":"Neuron"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1001\/jama.2010.574","article-title":"Genome-wide analysis of genetic loci associated with Alzheimer disease","volume":"303","author":"S Seshadri","year":"2010","journal-title":"JAMA"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/sj.onc.1203325","article-title":"Novel polymorphism in p21(waf1\/cip1) cyclin dependent kinase inhibitor gene: association with human esophageal cancer","volume":"19","author":"R Bahl","year":"2000","journal-title":"Oncogene"},{"key":"ref17","first-page":"3021","article-title":"A single nucleotide substitution at codon 31 (Ser\/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1\/CIP1","volume":"9","author":"M Chedid","year":"1994","journal-title":"Oncogene"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1078-1439(01)00152-1","article-title":"p21 gene codon 31 polymorphism is associated with bladder cancer","volume":"7","author":"WC Chen","year":"2002","journal-title":"Urol Oncol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2424::AID-CNCR19>3.0.CO;2-T","article-title":"Association between human cancer and two polymorphisms occurring together in the p21Waf1\/Cip1 cyclin-dependent kinase inhibitor gene","volume":"79","author":"EA Facher","year":"1997","journal-title":"Cancer"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/mutage\/ger010","article-title":"P21 codon 31 polymorphism associated with cancer among white people: evidence from a meta-analysis involving 78 074 subjects","volume":"26","author":"F Liu","year":"2011","journal-title":"Mutagenesis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/hmg\/4.6.1089","article-title":"Two variants of the CIP1\/WAF1 gene occur together and are associated with human cancer","volume":"4","author":"S Mousses","year":"1995","journal-title":"Hum Mol Genet"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000154357","article-title":"Association between the p21 codon 31 A1 (arg) allele and lung cancer","volume":"46","author":"A Sjalander","year":"1996","journal-title":"Hum Hered"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.bbadis.2006.11.001","article-title":"The dysregulation of the cell cycle and the diagnosis of Alzheimer\u2019s disease","volume":"1772","author":"Z Nagy","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1212\/WNL.57.9.1663","article-title":"Genome-wide linkage disequilibrium mapping of late-onset Alzheimer\u2019s disease in Finland","volume":"57","author":"M Hiltunen","year":"2001","journal-title":"Neurology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ajmg.b.30114","article-title":"Genome screen for loci influencing age at onset and rate of decline in late onset Alzheimer\u2019s disease","volume":"135B","author":"P Holmans","year":"2005","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/archneur.63.11.1591","article-title":"Expanded genomewide scan implicates a novel locus at 3q28 among Caribbean hispanics with familial Alzheimer disease","volume":"63","author":"JH Lee","year":"2006","journal-title":"Arch Neurol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1038\/sj.onc.1202923","article-title":"Control of E2F activity by p21Waf1\/Cip1","volume":"18","author":"L Delavaine","year":"1999","journal-title":"Oncogene"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/sj.onc.1202104","article-title":"Cell cycle arrest and DNA endoreduplication following p21Waf1\/Cip1 expression","volume":"17","author":"S Bates","year":"1998","journal-title":"Oncogene"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"F753","DOI":"10.1152\/ajprenal.00252.2002","article-title":"HCaRG is a novel regulator of renal epithelial cell growth and differentiation causing G2M arrest","volume":"284","author":"AM Devlin","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1210\/mend.13.10.0359","article-title":"Calcitonin receptor-mediated growth suppression of HEK-293 cells is accompanied by induction of p21WAF1\/CIP1 and G2\/M arrest","volume":"13","author":"A Evdokiou","year":"1999","journal-title":"Mol Endocrinol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1677\/jme.0.0250195","article-title":"Identification of a novel calcitonin-response element in the promoter of the human p21WAF1\/CIP1 gene","volume":"25","author":"A Evdokiou","year":"2000","journal-title":"J Mol Endocrinol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.cellsig.2010.01.013","article-title":"Examination of the expanding pathways for the regulation of p21 expression and activity","volume":"22","author":"YS Jung","year":"2010","journal-title":"Cell Signal"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.4161\/cc.5.12.2863","article-title":"The intricacies of p21 phosphorylation: protein\/protein interactions, subcellular localization and stability","volume":"5","author":"ES Child","year":"2006","journal-title":"Cell Cycle"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.1073\/pnas.082123999","article-title":"Negative regulation of cell growth and differentiation by TSG101 through association with p21(Cip1\/WAF1)","volume":"99","author":"H Oh","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2415-5-5","article-title":"A polymorphism at codon 31 of gene p21 is not associated with primary open angle glaucoma in Caucasians","volume":"5","author":"T Ressiniotis","year":"2005","journal-title":"BMC Ophthalmol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/pro.34","article-title":"Residual structure within the disordered C-terminal segment of p21(Waf1\/Cip1\/Sdi1) and its implications for molecular recognition","volume":"18","author":"MK Yoon","year":"2009","journal-title":"Protein Sci"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pneurobio.2003.09.007","article-title":"Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the \u2018Dr. Jekyll and Mr. Hyde concept\u2019 of Alzheimer\u2019s disease or the yin and yang of neuroplasticity","volume":"71","author":"T Arendt","year":"2003","journal-title":"Prog Neurobiol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"363","DOI":"10.18632\/aging.100045","article-title":"The neuronal cell cycle as a mechanism of pathogenesis in Alzheimer\u2019s disease","volume":"1","author":"A Currais","year":"2009","journal-title":"Aging (Albany NY)"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1582-4934.2005.tb00485.x","article-title":"The last neuronal division: a unifying hypothesis for the pathogenesis of Alzheimer\u2019s disease","volume":"9","author":"Z Nagy","year":"2005","journal-title":"J Cell Mol Med"},{"issue":"4","key":"ref40","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.2044-8260.1995.tb01487.x","article-title":"CAMCOG\u2014a concise neuropsychological test to assist dementia diagnosis: socio-demographic determinants in an elderly population sample","volume":"34","author":"FA Huppert","year":"1995","journal-title":"Br J Clin Psychol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"G McKhann","year":"1984","journal-title":"Neurology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases","volume":"55","author":"AJ Hughes","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/brain\/awm111","article-title":"Evolution of cognitive dysfunction in an incident Parkinson\u2019s disease cohort","volume":"130","author":"CH Williams-Gray","year":"2007","journal-title":"Brain"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease","volume":"41","author":"SS Mirra","year":"1991","journal-title":"Neurology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"H Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/jnnp.63.6.749","article-title":"Neuropathological assessment of the lesions of significance in vascular dementia","volume":"63","author":"MM Esiri","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1749-6632.2000.tb06373.x","article-title":"Which vascular lesions are of importance in vascular dementia?","volume":"903","author":"MM Esiri","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00005072-199702000-00007","article-title":"The effects of additional pathology on the cognitive deficit in Alzheimer disease","volume":"56","author":"Z Nagy","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1002\/jnr.22392","article-title":"Synapse loss in dementias","volume":"88","author":"R Clare","year":"2010","journal-title":"J Neurosci Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0304-3940(95)11484-E","article-title":"Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205","volume":"189","author":"M Goedert","year":"1995","journal-title":"Neurosci Lett"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1212\/WNL.56.1.127","article-title":"Altered expression of synaptic proteins occurs early during progression of Alzheimer\u2019s disease","volume":"56","author":"E Masliah","year":"2001","journal-title":"Neurology"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00001756-200301200-00017","article-title":"DC11: a novel monoclonal antibody revealing Alzheimer\u2019s disease-specific tau epitope","volume":"14","author":"L Vechterova","year":"2003","journal-title":"Neuroreport"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1073\/pnas.97.8.4291","article-title":"Effects of p21Waf1\/Cip1\/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases","volume":"97","author":"BD Chang","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.vascn.2004.08.014","article-title":"HEK293 cell line: a vehicle for the expression of recombinant proteins","volume":"51","author":"P Thomas","year":"2005","journal-title":"J Pharmacol Toxicol Methods"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1472-6750-7-71","article-title":"Enhancement of cell proliferation in various mammalian cell lines by gene insertion of a cyclin-dependent kinase homolog","volume":"7","author":"P Jaluria","year":"2007","journal-title":"BMC Biotechnol"},{"key":"ref56","article-title":"Cytometry: Methods in Cellular Biology","author":"Z Darzynkierricz","year":"2001"},{"key":"ref57","first-page":"83","article-title":"Analysis of DNA\u2014general methods","author":"M Ormerod","year":"2000"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000321984","article-title":"Apolipoprotein E epsilon4 prevalence in Alzheimer\u2019s disease patients varies across global populations: a systematic literature review and meta-analysis","volume":"31","author":"S Crean","year":"2011","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.devcel.2008.01.013","article-title":"CDK inhibitors: cell cycle regulators and beyond","volume":"14","author":"A Besson","year":"2008","journal-title":"Dev Cell"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/374386a0","article-title":"Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA","volume":"374","author":"J Chen","year":"1995","journal-title":"Nature"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/381804a0","article-title":"A non-enzymatic p21 protein inhibitor of stress-activated protein kinases","volume":"381","author":"J Shim","year":"1996","journal-title":"Nature"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/emboj\/18.5.1223","article-title":"Apoptosis inhibitory activity of cytoplasmic p21(Cip1\/WAF1) in monocytic differentiation","volume":"18","author":"M Asada","year":"1999","journal-title":"EMBO J"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0304-3940(01)01618-4","article-title":"Expression of apoptosis related proteins in brains of patients with Alzheimer\u2019s disease","volume":"303","author":"E Engidawork","year":"2001","journal-title":"Neurosci Lett"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.biocel.2010.04.007","article-title":"Actin cytoskeleton dynamics and the cell division cycle","volume":"42","author":"YW Heng","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.devcel.2009.08.012","article-title":"Actin dynamics at the leading edge: from simple machinery to complex networks","volume":"17","author":"RH Insall","year":"2009","journal-title":"Dev Cell"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"470","DOI":"10.18632\/aging.100041","article-title":"Identification of single nucleotide polymorphisms in the p21 (CDKN1A) gene and correlations with longevity in the Italian population","volume":"1","author":"S Gravina","year":"2009","journal-title":"Aging (Albany NY)"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1097\/00001756-199611250-00050","article-title":"Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer\u2019s disease","volume":"7","author":"T Arendt","year":"1996","journal-title":"Neuroreport"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s007020050104","article-title":"Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer\u2019s disease","volume":"105","author":"T Arendt","year":"1998","journal-title":"J Neural Transm"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/j.neurobiolaging.2010.04.017","article-title":"Cell cycle regulation distinguishes lymphocytes from sporadic and familial Alzheimer\u2019s disease patients","volume":"32","author":"E Bialopiotrowicz","year":"2011","journal-title":"Neurobiol Aging"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.neurobiolaging.2012.10.014","article-title":"Downregulation of extracellular signal-regulated kinase 1\/2 activity by calmodulin KII modulates p21Cip1 levels and survival of immortalized lymphocytes from Alzheimer\u2019s disease patients","volume":"34","author":"N Esteras","year":"2013","journal-title":"Neurobiol Aging"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/brain\/awr031","article-title":"Lewy- and Alzheimer-type pathologies in Parkinson\u2019s disease dementia: which is more important?","volume":"134","author":"Y Compta","year":"2011","journal-title":"Brain"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00401-008-0347-5","article-title":"Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease","volume":"115","author":"KA Jellinger","year":"2008","journal-title":"Acta Neuropathol"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"e68361","DOI":"10.1371\/journal.pone.0068361","article-title":"Cycle checkpoint abnormalities during dementia: a plausible association with the loss of protection against oxidative stress in Alzheimer\u2019s disease","volume":"8","author":"P Katsel","year":"2013","journal-title":"PLoS One"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"e57979","DOI":"10.1371\/journal.pone.0057979","article-title":"Altered processing of amyloid precursor protein in cells undergoing apoptosis","volume":"8","author":"T Fiorelli","year":"2013","journal-title":"PLoS One"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0306-4522(95)00331-C","article-title":"Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer\u2019s disease","volume":"69","author":"Z Nagy","year":"1995","journal-title":"Neuroscience"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/jnnp-2011-301413","article-title":"An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer\u2019s and Lewy body pathology","volume":"83","author":"C Wider","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2217\/bmm.12.56","article-title":"Relationship between genetic risk factors and markers for Alzheimer\u2019s disease pathology","volume":"6","author":"LS Elias-Sonnenschein","year":"2012","journal-title":"Biomark Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0114050","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T02:11:00Z","timestamp":1540347060000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0114050"}},"subtitle":[],"editor":[{"given":"Jaya","family":"Padmanabhan","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,1,27]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,1,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0114050","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,27]]}}}